AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00643708 — intervention group
Intervention type: PROCEDURE
Intervention: ovarian interstitial laser treatment
Description: Different dose of laser: group A, one point per ovary.
Study NCT00643708 — intervention group
Intervention type: PROCEDURE
Intervention: ovarian interstitial laser treatment
Description: Different dose of laser: group B, two points per ovary.
Study NCT00643708 — intervention group
Intervention type: PROCEDURE
Intervention: ovarian interstitial laser treatment
Description: Different dose of laser: group c, three points per ovary.
Study NCT04381481 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental Drink: Nutrition claim on fruit drinks
Description: Fruit drink contains a nutrition claim (task 1)
Study NCT00643708 — intervention group
Intervention type: PROCEDURE
Intervention: ovarian interstitial laser treatment
Description: Different dose of laser: group D, four-five points per ovary.
Study NCT02219906 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Resveratrol
Description: 1000mg tid
Study NCT02219906 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1000mg tid placebo
Study NCT04375826 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Epidural patient controlled analgesia
Description: The device is connected to the epidural catheter prior to surgery and drug administration is started during surgery. The continuous infusion rate is 4 ml / hr. When the button is pressed, 2 ml is additionally administered and the lock time is 20 minutes.
Study NCT04375826 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Preperitoneal analgesia and IV-PCA
Description: During surgery, the preperitoneal analgesia catheters are inserted into the preperitoneal space and these catheters are connected to the pump with ropivacaine.
Study NCT02410291 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational video
Description: Patients in the control group will receive standard patient education Patients in the experimental group will receive standard education and an educational video
Study NCT02637544 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: acupuncture
Description: classical acupuncture therapy
Study NCT02637544 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: acupuncture
Description: classical acupuncture therapy
Study NCT02430532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dimethyl fumarate
Description: capsule
Study NCT02430532 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: matched placebo capsule
Study NCT03995810 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Carnosine, capsulle, 2 g/day, 8 weeks
Description: We will administer supplemental carnosine (2 grams per day) for 8 weeks
Study NCT02997618 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community based exercise programme
Description: 20 week community (home or gym based) exercise programme
Study NCT02997618 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Usual care consisting of advice.
Study NCT02438800 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LARC First Video
Description: LARC First is an evidence-based, 12-minute video developed by the CHOICE project that features women of all racial and ethnic backgrounds describing LARC methods of contraception in simple, understandable language with summary text when appropriate.
Study NCT01899222 — intervention group
Intervention type: DEVICE
Intervention: Handheld fundus photography
Description: diagnostic imaging with two types of retina camera
Study NCT04249141 — intervention group
Intervention type: OTHER
Intervention: Survey and concept mapping
Description: ICU providers who participoated in SCCM ICU Liberation Collaborative will be invited to participate in surveys and a concept mapping excercise
Study NCT03408574 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine patch, oral mecamylamine, placebo
Description: Each participant randomly receives one active drug or placebo on each of three study days.
Study NCT04150874 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lumason®
Description: Hepatic artery embolization using standard of care radioembolization and assessment of tumor and hepatic parenchymal perfusion kinetics before, during and after treatment with standard of care iodinated contrast (at the time of Y90 radioembolization treatment) and standard of care follow-up with multiphase CT or MRI with the addition of study agent Lumason microbubbles for contrast-enhanced ultrasound (which will be performed concurrently with standard evaluation).
Study NCT02797405 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Standard treatment
Description: Sarcoma patients will undergo radiotherapy followed by surgery Rectum cancer patients will undergo radio-chemotherapy followed by surgery Esophagus cancer patients will undergo radio-chemotherapy followed by surgery
Study NCT02576418 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Partosure TTD test
Description: PartoSure TTD test and CL will be performed on all patients and the test-to-spontaneous-delivery interval will be calculated.
Study NCT02962336 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
Description: Oral, crossover
Study NCT02962336 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tribenzor Tablets of Daichi Sankyo Inc, USA
Description: Oral, crossover
Study NCT00841282 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Colonoscopy for colorectal cancer screening
Study NCT00841282 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Colonoscopy for colorectal cancer screening
Study NCT00841282 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Water Infusion Colonoscopy
Description: water infusion in lieu of air insufflation for screening colonoscopy
Study NCT00841282 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Air insufflation colonoscopy
Description: Conventional colonoscopy with air insufflation
Study NCT00368719 — intervention group
Intervention type: DRUG
Group type: NO_INTERVENTION
Intervention: Tacrolimus
Description: Participants will be followed for 10 years to study the effects of Tacrolimus.
Study NCT01738555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: amdoxovir 300 mg bid
Description: 2 x 150 mg capsules bid
Study NCT01738555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: amdoxovir 500 mg bid
Description: 2 x 250 mg capsules bid
Study NCT02952053 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MTrP Group
Description: Deep Dry Needling into the site of the latent medial Myofascial Trigger Point of the soleus muscle.~1 session in soleus muscle. 10 fast in and fast out needle insertions.
Study NCT02952053 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TB Group
Description: Deep Dry Needling distal to Myofascial Trigger Point but into the same taut band.~1 session in soleus muscle. 10 fast in and fast out needle insertions.
Study NCT01760044 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tissue oxygenation monitoring
Description: The device provides continuous measures with updates based on the previous 10 seconds worth of data. Data is continuously stored.
Study NCT04208867 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: QI Collaborative
Description: Facilities that participated in a QI collaborative to improve PCC for MH services
Study NCT03124108 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Elafibranor 80 mg
Description: Two coated tablets daily for 12 weeks
Study NCT03124108 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Elafibranor 120 mg
Description: Two coated tablets daily for 12 weeks
Study NCT03124108 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two coated tablets daily for 12 weeks
Study NCT02199145 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood and urine analysis
Description: creatinine, albumin, blood electrolytes, proteinuria / creatinine in sample 1 assay Ac anti-PLA2R1 on 3 ELISA (human, rabbit and mouse)
Study NCT03369301 — intervention group
Intervention type: DRUG
Intervention: Gammanorm
Description: Gammanorm given per standard of care
Study NCT03369301 — intervention group
Intervention type: DRUG
Intervention: Other Subcutaneous Immunoglobulins
Description: Other Subcutaneous Immunoglobulins given per standard of care
Study NCT00817986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arbaclofen placarbil, 20 mg
Description: tablets
Study NCT00817986 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: tablets
Study NCT00817986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arbaclofen placarbil, 30 mg
Description: tablets
Study NCT00817986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arbaclofen placarbil, 40 mg
Description: tablets
Study NCT03076619 — intervention group
Intervention type: OTHER
Intervention: clinical ophthalmoscopy
Description: To study the role of clinical ophthalmoscopy in PIH in diagnosis, prognosis, differential diagnosis, line of treatment and effect of treatment.
Study NCT00528177 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine and oxycodone
Description: At the end of surgery, group 1 will receive intravenous morphine 0.07 mg/kg and intravenous PCA morphine 0.015 mg/kg every time they push the botton with 5 minutes lock-out interval. Maximum 16 mg/2 hours. Group 2 will receive intravenous oxycodone 0.07 mg/kg and intravenous PCA oxycodone 0.015 mg/kg every time they push the botton with 5 minutes lock-out interval. Maximum 16 mg/2 hours.~The patients will use the PCA until the next morning.
Study NCT04381481 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control Drink: No nutrition claim
Description: Fruit drinks does not contain a nutrition claim (task 1)
Study NCT04381481 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental snack: Text warning
Description: The snack contains a text warning (task 2)
Study NCT03886727 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Rubber Dam Set
Description: Rubber dam set is the generic name of an isolation device that consists of a rubber sheet that isolates the tooth from saliva, a clamp to hold the rubber sheet on the tooth to be isolated, and a metal frame to keep the rubber sheet in a stretched position during dental procedures.
Study NCT03886727 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dental Cotton Roll
Description: Cotton roll is the generic name of a disposable isolation device made of cotton in a cylindrical form. Cotton rolls are used to isolate the teeth from saliva, by being placed in the cheek and tongue during placement of sealants or filings.
Study NCT01848964 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clinical and instrumented measurements
Description: Clinical examination will include stump pain, wound, scar and unusual shape.~Questionnaire will include satisfaction scale (SatPro), comfort scale (SCE), and functional scale (PPA-LCI)~After installing the sensors on the stump, the patient will put his prosthesis on and will perform the following tasks: gait, sitting and standing posture and gait initiation.~Pressure repartition at the stump-socket interface will be assessed with the 14 flat sensors.~Gait parameters will be assessed with the OptoGait device. Standing posture and gait initiation parameters will be assessed with a force-plate.
Study NCT03298178 — intervention group
Intervention type: PROCEDURE
Intervention: TAVR
Description: All patients who underwent transcatheter aortic valve replacement in Asan medical center, republic of Korea
Study NCT03298178 — intervention group
Intervention type: PROCEDURE
Intervention: SAVR
Description: All patients who underwent surgical aortic valve replacement in Asan medical center, republic of Korea
Study NCT04381481 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental snack: Graphic warning
Description: The snack contains a graphic warning (task 2)
Study NCT04381481 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control snack: barcode label
Description: The snack contains a neutral barcode label (task 2)
Study NCT00993603 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 8-month group lifestyle programme
Description: Dietary and lifestyle counselling (11 sessions), weekly exercise programme and 3 fasting blood samples at baseline, 4 and 8 months.
Study NCT04415489 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Office hysteroscopy
Description: Use of hysteroscopy in the clinical setting to directly visualize the cavity. If pathology amenable to immediate treatment is visualize, removal will be attempted by hysteroscopic graspers.
Study NCT02126111 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: DEPIGOID phleum
Description: Subcutaneous Immunotherapy with modified extract of Phleum pollen.
Study NCT02126111 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DEPIGOID phleum
Description: Subcutaneous Immunotherapy with modified extract of Phleum pollen.
Study NCT02126111 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: DEPIGOID Placebo
Description: Placebo for subcutaneous administration
Study NCT02568033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Study NCT02568033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Study NCT02568033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Study NCT02568033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Study NCT02568033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Study NCT02568033 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: stereotactic radiosurgery
Study NCT03545724 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neofitoroid®
Description: NeoFitoroid® forms a protective barrier mucosa and on perianal region that can aid the physiological process of healing.
Study NCT03951194 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Platelet Rich Plasma (PRP) intra ovarian infusion
Description: Autologous PRP intra ovarian infusion
Study NCT03951194 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo: Autologous Platelet Free Plasma (PFP) intra ovarian infusion
Description: Autologous PFP intra ovarian infusion
Study NCT01889472 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal mask and oral appliance vs oro-nasal mask during autoCPAP therapy
Study NCT01889472 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nasal mask and oral appliance vs oro-nasal mask during autoCPAP therapy
Study NCT04458558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mifepristone
Description: Participants will receive mifepristone at a preferred address by mail rather than standard care at clinic visit.
Study NCT01669031 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Practice program
Description: Each practice session (simulated visual field test on computer) takes 3-15 minutes
Study NCT00867854 — intervention group
Intervention type: OTHER
Intervention: Blood draw
Description: This sub-study does not involve additional treatment of any ATN 061 or ATN 071 study subjects. The only intervention involved is the requirement for whole blood collection (40 ml and 60 ml) to be drawn at the same time as four ATN 061 study visits (36, 48, 56, and 80 weeks) for subjects co-enrolled into ATN 061. When these time points coincide with ATN 061 Central Laboratory samples, the 60 ml blood sample will not be collected. For subjects co-enrolled into ATN 071, there are also two samples of whole blood collection (40 ml and 60 ml) required to be drawn at four time points but at weeks 36, 48, 56, and 80 after the initiation of HAART.
Study NCT03001024 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Implementation of WayToServe Español
Description: Following baseline assessment and randomization to experimental condition, premises assigned to the intervention condition will be contacted and recruited to the trial. Managers will provide a list of all servers. All servers will be registered by project staff on the WTS-E website and provided a unique identification code, which will track their use of the training and associate it with the premise. Servers will complete a profile on the program during their first login. Servers will be asked to complete the training within four weeks from initial registration; email and text reminders will be sent to those who do not login within one week of initial registration.
Study NCT03001024 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual and Customary RBS Training
Description: The premises randomized to the UC training condition will be, in effect, blind to the investigation. Server training is mandatory for all servers in New Mexico. Server training is voluntary in Texas but heavily incentivized by TABC's Safe Harbor clause. Under this clause, liquor licensees are held harmless for any service infractions if all servers are trained and certified by an approved RBS trainer; instead, the server is cited for the infraction.
Study NCT02495532 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lymph node clearing technique with Carnoy solution
Description: Procedure: lymph node clearing technique with Carnoy solution~(1) just after the surgical resection each specimen is fixed by formaldehyde; (2) lymph node harvesting is performed by a manual technique of vision and palpation; (3) lymph nodes retrieved are counted, stained with hematoxylin and eosin and examined with light microscopy; (4) the surgical specimen is submitted to re-fixation with Carnoy solution and another lymph node harvesting by manual technique of vision and palpation; (5) additional lymph nodes retrieved are counted, stained with hematoxylin and eosin and examined with light microscopy.
Study NCT01358851 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Cryotherapy
Description: 1-2 times during the treatment time
Study NCT01358851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LAS41005
Description: once daily
Study NCT00987545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QAX576
Description: QAX576 injection
Study NCT00987545 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: QAX576 placebo
Description: Placebo to QAX576 injection
Study NCT04659720 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hydrolic lifter device
Description: evaluation of implant stability after closed sinus lifting by hydraulic lift technique using hydraulic lifter device
Study NCT04659720 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient satisfaction evalution using hydraulic lifter device
Description: patients satisfaction will be evaluated numerically after using hydraulic lift technique by hydraulic lifter device for closed sinus lifting in posterior edentulous maxilla
Study NCT01549678 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Total contact insole
Description: EVA insole shaped on patient´s foot.
Study NCT01549678 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo insole
Description: EVA insole flat
Study NCT01512342 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pacing
Description: 3 one-on-one sessions weekly for 3 consecutive weeks
Study NCT01512342 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: relaxation therapy
Description: 3 one-on-one sessions weekly for 3 consecutive weeks
Study NCT01741090 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mesenchymal stem cell injection
Description: Hepatic artery catheterization and mesenchymal stem cell injection will be used in alcoholic liver cirrhosis. And before and 1 month after injection, change of liver cirrhosis and portal hypertension will be evaluated.
Study NCT02315989 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: proton therapy
Description: proton therapy
Study NCT01274650 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Indirect Calorimetry
Description: Indirect Calorimetry
Study NCT03626168 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 100% watermelon juice
Description: Participants drank two 12-ounce servings of 100% watermelon juice per day for a four-week period.
Study NCT03626168 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo beverage
Description: Participants drank two 12-ounce servings of a placebo beverage per day for a four-week period.
Study NCT01620554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BF2.649
Description: 1 capsule per week during 2 weeks
Study NCT01620554 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 capsule per week during 2 weeks
Study NCT01724879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib
Description: Dasatinib p.o. + Chemotherapy (Dexamethasone, Cyclophosphamide, Vincristine, Methotroxate, 6-Mercapto-Purine, Cytarabine, Vindesine, VP16 (Etoposide))
Study NCT01146912 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Text Message
Description: Text message vaccine reminders
Study NCT01146912 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: automated call
Description: Automated call
Study NCT01146912 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: automated call
Description: Automated call